Drugs for Panic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 219)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Etoricoxib |
Approved, Investigational |
Phase 4 |
|
202409-33-4 |
123619 |
Synonyms:
202409-33-4
5CH
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulphonyl)phenyl)pyridine
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine
5-chloro-3-(4-Methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-chloro-3-(4-Methanesulphonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-chloro-6'-Methyl-3-(P-(methylsulphonyl)phenyl)-2,3'-bipyridine
5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine
AC1L3WZM
Algix
Arcoxia
C11718
C422649
CHEBI:106706
CHEBI:6339
CHEMBL416146
CID123619
D03710
DB01628
|
DB07166
Etoricoxib
étoricoxib
Etoricoxib (USAN/INN)
Etoricoxib [USAN:INN:BAN]
Etoricoxibe
Etoricoxibum
FT-0082494
HMS2090A05
L001141
L791456
L-791456
LS-181802
Merck Sharp & Dohme brand of etoricoxib
MK 0663
MK 663
MK-0663
MK-663
MolPort-003-847-339
NCGC00164578-01
Nucoxia
Tauxib
UNII-WRX4NFY03R
ZINC00579472
|
|
2 |
|
Paroxetine |
Approved, Investigational |
Phase 4 |
|
61869-08-7 |
43815 |
Synonyms:
(−)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
(-)-Paroxetine
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
[3H]Paroxetine
110429-35-1
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
61869-08-7
63952-24-9
64006-44-6 (maleate)
78246-49-8 (hydrochloride)
AB00514724
AC1L2AKL
AC1Q1H18
AC1Q4LV6
Acetate, paroxetine
Anhydrous, paroxetine hydrochloride
Aropax
BIDD:GT0673
BPBio1_000949
BRD-K37991163-003-02-7
BRL 29060
BRL-29060
BSPBio_000861
C07415
C19H20FNO3
Casbol
CHEBI:7936
CHEMBL490
CID43815
D02362
DB00715
DivK1c_006884
FG 7051
FG-7051
Frosinor
FT-0085087
Hemihydrate paroxetine hydrochloride
Hemihydrate, paroxetine hydrochloride
HMS2090H05
Hydrochloride anhydrous, paroxetine
Hydrochloride hemihydrate, paroxetine
Hydrochloride, hemihydrate paroxetine
|
Hydrochloride, paroxetine
I14-7752
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
KBioSS_002232
LS-114249
Maleate, paroxetine
MolPort-003-849-791
Motivan
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NNC-20-7051
Paroxetina
Paroxetina [INN-Spanish]
paroxetine
Paroxetine
Paroxetine (TN)
Paroxetine (USP/INN)
Paroxetine [USAN:INN:BAN]
Paroxetine acetate
Paroxetine Hcl
Paroxetine hydrochloride
Paroxetine hydrochloride anhydrous
Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride, hemihydrate
Paroxetine maleate
Paroxetine, cis-(-)-isomer
Paroxetine, cis-(+)-isomer
Paroxetine, trans-(+)-isomer
Paroxetinum
Paroxetinum [INN-Latin]
Paxetil
Paxil
Paxil CR
PaxPar
Pexeva
Prestwick3_000851
Seroxat
Seroxat CR
SpecPlus_000788
Spectrum_001752
Spectrum5_001665
TL8003967
UNII-41VRH5220H
|
|
3 |
|
Norepinephrine |
Approved |
Phase 4 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(-)-Arterenol free base
(−)-noradrenaline
(-)-Noradrenaline
(-)-NORADRENALINE
(−)-norepinephrine
(-)-Norepinephrine
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-Noradrenaline
(R)-norepinephrine
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-amino-1-Hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
Abbott brand OF levophed bitartrate
AC1L96ZT
Adrenor
Aktamin
ALBB-006229
Arterenol
Aventis brand OF norepinephrine hydrochloride
Bitartrate, levophed
Bitartrate, noradrenaline
Bitartrate, norepinephrine
bmse000404
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
Hydrochloride, norepinephrine
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
L-3,4-dihydroxyphenylethanolamine
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-Arterenol
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
|
Levophed
Levophed bitartrate
L-noradrenaline
L-Noradrenaline
L-Norepinephrine
L-NOREPINEPHRINE
LS-42676
LT03330026
LT4
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
noradrenaline
Noradrenaline
Nor-adrenaline
Noradrenaline (JP15)
Noradrenaline bitartrate
Noradrénaline tartrate renaudin
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
norepinefrina
Norepinefrina
Norepinephrin D-tartrate (1:1)
norepinephrine
Norepinephrine
Norépinéphrine
Norepinephrine (INN)
Norepinephrine [INN:JAN]
Norepinephrine bitartrate
Norepinephrine D-tartrate (1:1)
Norepinephrine hydrochloride
Norepinephrine hydrochloride, (+)-isomer
Norepinephrine hydrochloride, (+,-)-isomer
Norepinephrine l-Tartrate (1:1)
Norepinephrine L-tartrate (1:1)
Norepinephrine L-tartrate (1:1), (+,-)-isomer
Norepinephrine L-tartrate (1:1), monohydrate
Norepinephrine L-tartrate (1:1), monohydrate, (+)-isomer
Norepinephrine L-tartrate (1:2)
Norepinephrine L-tartrate, (+)-isomer
Norepinephrine Noradrenalin
Norepinephrine, (+)-isomer
Norepinephrine, (+,-)-isomer
norepinephrinum
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
Nor-epirenan
PDSP1_001111
PDSP2_001095
Renaudin brand OF norepinephrine bitartrate
Renaudin, noradrénaline tartrate
SGCUT00123
SPBio_001048
Spectrum_001009
SPECTRUM1500436
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
STK503776
Sympathin e
Sympathin E
Tartrate renaudin, noradrénaline
to_000024
UNII-X4W3ENH1CV
|
|
4 |
|
Propranolol |
Approved, Investigational |
Phase 4 |
|
525-66-6 |
4946 |
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(isopropylamino)-3-(1-Naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
13013-17-7
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
AY 64043
AY-20694
Bedranol
Beprane
Berkolol
Beta Neg
Betachron
Betadren
Betalong
Beta-Neg
beta-Propranolol
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
BPBio1_001040
b-Propranolol
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
C07407
C16H21NO2
Cardinol
Caridolol
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
cMAP_000071
Corpendol
D,L-Propranolol
D08443
DB00571
Deralin
Dexpropranolol
DivK1c_000023
Dl-Propranolol Hydrochloride
DL-Propranolol hydrochloride
Dociton
Duranol
Efektolol
EINECS 208-378-0
EINECS 235-867-6
Elbrol
etalong
Etalong
Euprovasin
Frekven
Herzbase
HMS2090L21
Hydrochloride, propranolol
ICI 45520
IDI1_000023
Ikopal
Inderal
Inderal hydrochloride
Inderal La
Inderalici
Inderex
Inderide
INDERIDE-40/25
INDERIDE-80/25
|
Inderol
Indobloc
Innopran XL
InnoPranXL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
Lopac0_000896
LS-122410
LS-184129
Migrastat
MolPort-001-794-623
Naprilin
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Pranolol
Prano-Puren
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
propranolol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol [INN:BAN]
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol hydrochloride
Propranolol Hydrochloride
propranololo
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor line
Reducor Line
Rexigen
Sagittol
Sawatal
Servanolol
Sloprolol
SPBio_001361
SPBio_001658
SPBio_003093
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
STK735510
Sumial
Tesnol
UNII-9Y8NXQ24VQ
β-propranolol
β-Propranolol
|
|
5 |
|
Oxytocin |
Approved, Vet_approved |
Phase 4 |
|
50-56-6 |
53477758 439302 |
Synonyms:
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
(Arg8)-vasopressin
(Arg8)-vasotocin
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
50-56-6
AC1L9735
alpha-Hypophamine
Argipressin
Argpressin acetate
BCBcMAP01_000094
Biotinyl-(arg8)-vasopressin
C00746
CHEBI:492195
CHEBI:7872
CHEMBL395429
CID439302
Cys-tyr-ile-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-ile-GLN-asn-cys-pro-leu-gly-NH2
Cys-tyr-ile-THR-asn-cys-gly-leu-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-lys-gly-NH2
D00089
Disulfide bridge cys1-cys6
Gly-leu-pro-c
HS-2021
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
|
MolPort-003-938-941
NCGC00167132-01
nchembio.184-comp2
O3251_SIGMA
O4375_SIGMA
Ocytocin
Oxitocina
OXT
Oxytocic hormone
Oxytocin
OXYTOCIN
Oxytocin (JP15/USP/INN)
Oxytocin (TN)
Oxytocin 10 usp units in dextrose 5%
Oxytocin 20 usp units in dextrose 5%
Oxytocin 5 usp units in dextrose 5%
Oxytocin acetate
Oxytocin injection
Oxytocine
Oxytocinum
Pitocin
Pitocin (TN)
Syntocinon
Syntocinon (TN)
TI-001
|
|
6 |
|
Clonazepam |
Approved, Illicit |
Phase 4 |
|
1622-61-3 |
2802 |
Synonyms:
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-dihydro-7-nitro-5-(2-Chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-chloro-Phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-24-04-00351 (Beilstein Handbook Reference)
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
AC-15733
AC1L1EI2
Alti-Clonazepam
Antelepsin
Antilepsin
BAS 00308658
BIDD:PXR0144
BRN 0759557
C1277_SIGMA
C15H10ClN3O3
CHEBI:3756
CHEMBL452
Chlonazepam
CID2802
Cloazepam
clonazepam
Clonazepam
Clonazepam (JP15/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
D00280
D002998
|
DB01068
DEA No. 2737
DF2374250
DivK1c_000973
EINECS 216-596-2
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
Landsen
Lktorivil
Lonazep
LS-34156
LS-34260
Melzap
MolPort-001-729-088
NINDS_000973
NIOSH/DF2374250
NSC 179913
NSC179913
Oprea1_168772
Paxam
Ravotril
Rivatril
Rivoril
Rivotril
Ro 4023
Ro 4-8180
Ro 54023
Ro 5-4023
Ro 5-4023/B-7
RO4023
Ro-5-4023
Solfidin
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC03813003
|
|
7 |
|
Vortioxetine |
Approved, Investigational |
Phase 4 |
|
508233-74-7 |
9966051 |
Synonyms:
BRINTELLIX
Vortioxetina
Vortioxetine
|
Vortioxétine
vortioxetinum
|
|
8 |
|
Aripiprazole |
Approved, Investigational |
Phase 4 |
|
129722-12-9 |
60795 |
Synonyms:
||OPC 14597
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
Abilify
Abilify (TN)
Abilify Discmelt
Abilitat
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
aripiprazol
Aripiprazol
aripiprazole
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
aripiprazolum
Aripiprazolum
Aripirazole
Arpizol
Asprito|
Bio-0004
BMS-337039
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
|
CHEMBL1112
CID60795
CPD000466383
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
Opc 14597
OPC 31
OPC-14597
OPC-31
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
|
|
9 |
|
Clozapine |
Approved |
Phase 4 |
|
5786-21-0 |
2818 |
Synonyms:
3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
5786-21-0
8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine
8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
AC1L1EJE
AC1Q3OPZ
AC1Q3ZWP
AC-280
AKOS005064444
AR-1I2412
Asaleptin
Bio1_000436
Bio1_000925
Bio1_001414
Bio2_000310
Bio2_000790
BRD-K37289225-001-09-1
BRN 0764984
C 6305
C06924
C18H19ClN4
C6305_SIGMA
CAS-5786-21-0
CCRIS 9171
CHEBI:3766
CHEMBL42
CID2818
Clorazil
Clozapin
Clozapina
Clozapina [INN-Spanish]
clozapine
Clozapine
Clozapine (JAN/USP/INN)
Clozapine [USAN:INN:BAN]
clozapine(tautomer)
Clozapinum
Clozapinum [INN-Latin]
Clozaril
CLOZARIL
Clozaril (TN)
CPD000058365
D00283
D003024
DB00363
DivK1c_000343
EINECS 227-313-7
EU-0100276
Fazaclo
Fazaclo ODT
FT-0082373
HF1854
HF-1854
HMS1361P12
HMS1569E21
HMS1791P12
HMS1921C16
HMS1989P12
HMS2089L13
HMS2092I16
|
HMS501B05
HSDB 6478
I06-0047
InChI=1/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3
Iprox
KBio1_000343
KBio2_000310
KBio2_000599
KBio2_002878
KBio2_003167
KBio2_005446
KBio2_005735
KBio3_000619
KBio3_000620
KBio3_002979
KBioGR_000310
KBioGR_001336
KBioSS_000310
KBioSS_000599
KS-1166
L000195
L013417
Leponex
Lepotex
LEX-123
Lopac-C-6305
LS-60881
LX 100-129
MLS000028472
MLS001077282
MolPort-001-728-041
NCGC00015254-01
NCGC00015254-02
NCGC00015254-03
NCGC00015254-07
NCGC00015254-17
NCGC00022902-02
NCGC00022902-04
NCGC00022902-05
NCGC00022902-06
NCGC00022902-07
NCGC00022902-08
NCGC00022902-09
NCGC00022902-10
NCGC00022902-11
NCGC00022902-13
NINDS_000343
Prestwick_693
Prestwick0_000350
Prestwick1_000350
S2459_Selleck
SAM002548976
SMR000058365
SPBio_000798
SPBio_002340
Spectrum_000139
SPECTRUM1500685
Spectrum2_000919
Spectrum3_001828
Spectrum4_000898
Tocris-0444
UNII-J60AR2IKIC
W-801
|
|
10 |
|
Ziprasidone |
Approved |
Phase 4 |
|
146939-27-7 |
60854 |
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-(2-(4-(3-Benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
Geodon
|
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
ziprasidona
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone hydrochloride, monohydrate
Ziprasidone mesylate trihydrate
ziprasidonum
Ziprasidonum
ziprazidone
Ziprazidone
|
|
11 |
|
Valproic acid |
Approved, Investigational |
Phase 4 |
|
99-66-1 |
3121 |
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 PP (base)
2 Propylpentanoic acid
2-N-Propyl-N-valerate
2-n-propyl-n-valeric acid
2-n-Propyl-n-valeric acid
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-propyl-pentanoic acid
2-Propylpentanoic acid
2-Propylpentanoic Acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-propylvaleric acid
2-Propylvaleric acid
2-Propylvaleric Acid
4-Heptanecarboxylate
4-heptanecarboxylic acid
4-Heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
Abbott 44090
AC1L1F7T
AC1Q2ULA
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acide valproique [INN-French]
acido Valproico
Acido valproico
ácido valproico
Acido valproico [INN-Spanish]
acidum valproicum
Acidum valproicum
Acidum valproicum [INN-Latin]
AI3-10500
Alti-valproic
Alti-Valproic
apo-Divalproex
apo-Valproic
apo-Valproic syrup
Avugane
Baceca
BIDD:GT0858
BRN 1750447
C07185
Calcium valproate
Calcium, valproate
CHEBI:39867
CHEMBL109
CID3121
Convulex
Convulsofin
CPD000499581
D00399
DB00313
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Deproic
Di-N-propylacetate
di-n-propylacetic acid
Di-n-propylacetic acid
Di-N-propylacetic acid
Di-n-propylessigsaeure
Di-N-propylessigsaeure
Di-n-propylessigsaure
Di-N-propylessigsaure
Di-n-propylessigsäure
Di-n-propylessigsaure [German]
Dipropyl acetate
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DivK1c_000273
DOM-divalproex
Dom-valproate
Dom-Valproic
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
EINECS 202-777-3
Epiject i.v.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
|
KBio2_004845
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
Magnesium valproate
Med valproic
Med Valproic
MLS001076682
MLS001335927
MLS001335928
MLS002415770
MolPort-001-791-895
Mylproin
Myproate
Myproic acid
Myproic Acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
nchembio.79-comp4
nchembio815-comp21
n-Dipropylacetic acid
N-Dipropylacetic acid
n-DPA
N-DPA
NINDS_000273
novo-Divalproex
novo-Valproic
Novo-Valproic
novo-Valproic - ecc
novo-Valproic soft gel cap
NSC 93819
NSC93819
Nu-valproic
Nu-Valproic
P0823
P6273_SIGMA
PEAC
Penta-valproic
Penta-Valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic Acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
ratio-Valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
Sandoz valproic
Savicol
SBB065764
Semisodium valproate
Semisodium Valproate
SMR000499581
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
SPBio_000912
Spectrum_000521
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Sprinkle
Stavzor
UNII-614OI1Z5WI
Valcote
Valparin
valproate
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
valproic acid
Valproic acid
VALPROIC ACID
Valproic acid (USP)
Valproic acid [USAN:INN:BAN]
Valproic acid usp
Valproic acid USP
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproic Acid, Sodium Salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
WLN: QVY3 & 3
|
|
12 |
|
Bupropion |
Approved |
Phase 4 |
|
34911-55-2, 34841-39-9 |
444 |
Synonyms:
( -)-2-(tert-Butylamino)-3'-chloropropiophenone
( -)-2-(tert-Butylamino)-3'-chlorpropiophenon
(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
.alpha.-(tert-Butylamino)-m-chloropropiophenone
1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
2-(Tert-Butylamino)-3'-chloropropiophenone
34841-36-6 (hydrochloride)
34841-39-9
34911-55-2
AB00053756
AC-197
AC1L198Y
alpha-(tert-butylamino)-m-chloropropiophenone
Amfebutamon
Amfebutamona
Amfebutamona [INN-Spanish]
Amfebutamone
AMFEBUTAMONE HCl
amfebutamonum
Amfebutamonum
Amfebutamonum [INN-Latin]
BPBio1_000042
BRD-A05186015-003-05-7
BRN 2101062
BSPBio_000038
BSPBio_002247
bupropion
Bupropion
Bupropion (INN)
Bupropion (Old RN)
Bupropion (USAN)
Bupropion [INN:BAN]
Bupropion Hcl
Bupropion hydrochloride
Bupropion hydrochloride, (+-)-isomer
Bupropion hydrocloride
Bupropion SR
Bupropion, (+-)-isomer
C06860
CHEBI:3219
CHEMBL894
CID444
CPD000472526
D07591
DB01156
DivK1c_007050
Elont
|
Esteve brand OF bupropion hydrochloride
glaxo Wellcome brand 1 OF bupropion hydrochloride
glaxo Wellcome brand 2 OF bupropion hydrochloride
glaxo Wellcome brand 3 OF bupropion hydrochloride
GlaxoSmithKline brand 1 OF bupropion hydrochloride
GlaxoSmithKline brand 2 OF bupropion hydrochloride
HMS2051G10
HMS2089G14
Jsp006301
KBio1_001994
KBio2_002143
KBio2_004711
KBio2_007279
KBio3_001467
KBioGR_001168
KBioSS_002143
L000725
Lopac0_000166
LS-122817
MLS001424015
MolPort-003-845-432
NCGC00015122-06
NCGC00089751-02
NCI60_002714
NSC315851
Prestwick0_000249
Prestwick1_000249
Prestwick2_000249
Prestwick3_000249
Quomen
SAM001246699
SMR000472526
SPBio_001817
SPBio_002257
SpecPlus_000954
Spectrum_001663
Spectrum2_001659
Spectrum3_000644
Spectrum4_000614
Spectrum5_001406
TL8002604
UNII-01ZG3TPX31
Wellbatrin
Wellbutrin
Wellbutrin SR
Wellbutrin XL
Zyban
Zyban (anti-smoking)
Zyntabac
|
|
13 |
|
Ketamine |
Approved, Vet_approved |
Phase 4 |
|
6740-88-1 |
3821 |
Synonyms:
(-)-Ketamine
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(±)-ketamine
(S)-(-)-Ketamine
(S)-Ketamine
100477-72-3
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chloro-Phenyl)-2-methylamino-cyclohexanone
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-Chlorophenyl)cyclohexanone
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(O-Chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
Calipsol
Calypsol
Cetamina
Cetamina [INN-Spanish]
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
DEA No. 7285
DivK1c_000217
|
dl-Ketamine
DL-ketamine
DL-Ketamine
EINECS 229-804-1
Esketamine
Green
IDI1_000217
Kalipsol
KBio1_000217
Ketaject
Ketalar
Ketalar base
Ketamina
ketamine
Ketamine
Kétamine
Ketamine (INN)
Ketamine [INN:BAN]
Ketamine base
Ketamine Base
Ketamine HCL
KETAMINE HCL
Ketamine hydrochloride
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketaset
Ketoject
Ketolar
l-Ketamine
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
|
|
14 |
|
Dronabinol |
Approved, Illicit |
Phase 4 |
|
1972-08-3 |
16078 |
Synonyms:
&Delta
(-)- delta 9-Tetrahydrocannabinol
(-)-.delta.(sup9)-trans-Tetrahydrocannabinol
(-)-.DELTA.1-Tetrahydrocannabinol
(-)-.DELTA.9-Tetrahydrocannabinol
(-)-.DELTA.9-THC
(-)-.DELTA.9-trans-Tetrahydrocannabinol
(-)-3,4-trans-Delta1-Tetrahydrocannabinol
(-)-delta 1-Tetrahydrocannabinol
(-)-delta 9-THC
(-)-delta 9-trans-Tetrahydrocannabinol
(-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol
(-)-delta1-Tetrahydrocannabinol
(-)-delta9-(trans)-Tetrahydrocannabinol
(-)-delta9-Tetrahydrocannabinol
(-)-delta9-trans-Tetrahydrocannabinol
(-)-trans-.DELTA.9-Tetrahydrocannabinol
(-)-trans-delta 1-Tetrahydrocannabinol
(-)-trans-delta 9-Tetrahydrocannabinol
(-)-trans-delta 9-THC
(-)-trans-Delta1-Tetrahydrocannabinol
(-)-trans-delta9-Tetrahydrocannabinol
(-)-trans-Delta9-THC
(-)-Δ9-trans-tetrahydrocannabinol
(L)-.delta.1-Tetrahydrocannabinol
(L)-delta 1-Tetrahydrocannabinol
(l)-delta(sup 1)-Tetrahydrocannabinol
(l)-delta1-Tetrahydrocannabinol
.delta.(sup9)-THC
.DELTA.1-Tetrahydrocannabinol
.DELTA.1-THC
.delta.-9-THC
.DELTA.9-THC
.DELTA.9-trans-Tetrahydrocannabinol
1363-19-5
14146-29-3
14146-43-1
14C-.DELTA.1-Tetrahydrocannabinol
14C-delta 1-Tetrahydrocannabinol
1972-08-3
1-trans-.delta.(sup9)-tetrahydrocannabinol
1-trans-D9-Tetrahydrocannabinol
1-trans-delta 9-Tetrahydrocannabinol
1-trans-delta(sup 9)-Tetrahydrocannabinol
1-trans-delta(sup9)-tetrahydrocannabinol
1-trans-delta9-Tetrahydrocannabinol
1-trans-delta-9-Tetrahydrocannabinol
1-trans-Δ-9-tetrahydrocannabinol
26108-45-2
308064-99-5
3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol
3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol
5957-27-7
6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
6465-30-1
6H-Dibenzo
9 Ene tetrahydrocannabinol
9-delta-Tetrahydrocannabinol
9-ene-Tetrahydrocannabinol
9-Ene-tetrahydrocannabinol
9-tetrahydrocannabinol
9-THC
Abbott 40566
AC1L277U
AC1Q2VRZ
BIDD:GT0427
C06972
Cannabinol, Delta1-tetrahydro- (7CI)
Cannabinol, tetrahydro- (6CI)
Cannabis resin
CAT-310
CCRIS 4726
CHEBI:104496
CHEMBL465
CID16078
Compassia
D00306
DB00470
Dea No. 7369
DEA No. 7369
Dea No. 7370
DEA No. 7370
delta 1-Tetrahydrocannabinol
delta 1-THC
delta 9-Tetrahydrocannabinol
delta 9-THC
delta 9-trans-Tetrahydrocannabinol
delta(1)-tetrahydrocannabinol
delta(1)-Tetrahydrocannabinol
Delta(1)-Tetrahydrocannabinol
delta(1)-THC
delta(9)-Tetrahydrocannabinol
delta(9)-Tetrahydrocannibinol
delta(9)-THC
Delta(9)-THC
delta(sup 1)-Tetrahydrocannabinol
delta(sup 1)-Thc
|
delta(sup 9)-Tetrahydrocannabinol
delta(sup 9)-Thc
delta1-Tetrahydrocannabinol
delta1-Tetrahydrocannabinol (VAN)
delta1-THC
delta9-tetrahydrocannabinol
delta-9-tetrahydrocannabinol
delta9-Tetrahydrocannabinol
DELTA-9-TETRAHYDROCANNABINOL
delta9-Tetrahydrocannabinol (VAN)
Delta9-Tetrahydrocannabinol solution
delta9-THC
delta-9-THC
DELTA-9-THC
delta9-trans-Tetrahydrocannabinol
Deltanyne
delta-THC
DRG-0138
Drona binol
Dronabinol
Dronabinol (USP/INN)
Dronabinol [Usan:Inn]
Dronabinol [USAN:INN]
Dronabinolum
Dronabinolum [Latin]
EPA 28
EPA-PLUS
Exocyclic delta (9)(11)-tetrahydrocannabiol
Fats and Glyceridic oils, fish, n-3 fatty acid-high
Fish oils, n-3 fatty acid-high
Fish oils, omega-3 fatty acid-high
Ganja
Hashish
HSDB 6471
L-.delta.1-Tetrahydrocannabinol
L-.delta.1-trans-Tetrahydrocannabinol
L-delta 1-trans-Tetrahydrocannabinol
L-delta(sup 1)-tetrahydrocannabinol
L-delta1-trans-Tetrahydrocannabinol
LS-975
L-trans-.delta.9-Tetrahydrocannabinol
L-trans-delta 9-Tetrahydrocannabinol
L-trans-delta9-Tetrahydrocannabinol
Marincap
Marinol
Marinol (TN)
MaxEPA
MolPort-003-959-698
Namisol
nchembio.129-comp1
nchembio.552-comp1
nchembio.86-comp3
NSC 134454
NSC134454
omega-3-Fatty acid
Omegaven
PDSP2_000714
Primolut
Promega
Pro-Mega
QCD 84924
QCD-84924
Relivar
Solvay brand OF tetrahydrocannabinol
Sonergx
SP 104
Syndros
T2386_SIGMA
T4764_FLUKA
T4764_SIGMA
Tetrahydrocannabinol
TETRAHYDROCANNABINOL
Tetrahydrocannabinol delta9
Tetrahydrocannabinol, (6ar-cis)-isomer
Tetrahydrocannabinol, (6as-cis)-isomer
Tetrahydrocannabinol, (6a-trans)-isomer
Tetrahydrocannabinol, trans isomer
Tetrahydrocannabinol, trans-(+-)-isomer
Tetrahydrocannabinol, trans-isomer
Tetrahydrocannabinols (-)-delta1-3,4-trans-form
Tetranabinex
THC
THC-delta-9
trans-.DELTA.9-Tetrahydrocannabinol
trans-delta (-)-9-Tetrahydrocannabinol
trans-delta 9-Tetrahydrocannabinol
trans-delta9-Tetrahydrocannabinol
trans-delta-9-Tetrahydrocannabinol
trans-tetrahydrocannabinol
UNII-7J8897W37S
ZINC01530625
Δ(1)-tetrahydrocannabinol
Δ(9)-THC
Δ9-tetrahydrocannabinol
Δ-9-tetrahydrocannabinol
Δ-9-THC
|
|
15 |
|
Mifepristone |
Approved, Investigational |
Phase 4 |
|
84371-65-3 |
55245 |
Synonyms:
(11beta,17beta)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one
(11beta,17beta)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one
(11beta,17beta)-11-(4-(Dimethylamino)-phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one
(11beta,17beta)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-prop-1-yn-1-ylestra-4,9-dien-3-one
(2E)-N-hydroxy-3-[4-({(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide
(8S,11R,13S,14S,17S)-11-(4-dimethylaminophenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(E)-N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide
11-(4-dimethylamino-PHENYL)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one
11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17-PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC AHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE
11beta-(4-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-on
11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-21-methyl-19-nor-17alpha-pregna-4,9-dien-20-m-3-on
11beta-(4-(N,N-Dimethylamino)phenyl)-17alpha-(prop-1-ynyl)-delta4,9-estradiene-17beta-ol-3-one
11beta-(4-Dimethyl-?amino)-?phenyl-17beta-hydroxy-17-(1-propynyl)-?estra-4,9-dien-3-one
11beta-(p-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one
122742-25-0
17-beta-Hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one
404951-53-7
83203-42-3
84371-65-3
AC1L1IOO
AC1O62SB
Ambap84371-65-3
BIDD:PXR0123
BPBio1_000262
BRD-K37270826-001-04-5
BRN 5779404
BSPBio_000238
C07652
C-1073
C29H35NO2
CHEBI:50692
CHEMBL157
CHEMBL356066
CI-1073
CID55245
CID6445533
Contragest brand OF mifepristone
Contragest Brand of Mifepristone
Corlux
CPD000058481
D00585
D015735
Dacinostat
danco Brand OF mifepristone
Danco Brand of Mifepristone
DB00834
EC-000.2469
EU-0100801
Exelgyn brand OF mifepristone
Exelgyn Brand of Mifepristone
FT-0082666
HMS1568L20
HMS2052L05
HMS2090L22
HSCI1_000369
HSDB 6841
I14-11726
LAQ-824
Lopac0_000801
LS-192513
LS-64723
M 8046
M8046_SIGMA
Mifegyne
|
Mifégyne
Mifeprex
Mifeprex (TN)
Mifepriston
Mifepristona
Mifepristona [Spanish]
mifepristone
Mifepristone
Mifépristone
Mifepristone (USAN/INN)
Mifepristone [USAN:INN:BAN]
Mifepristone contragest brand
Mifepristone Contragest Brand
Mifepristone danco brand
Mifepristone Danco Brand
Mifepristone exelgyn brand
Mifepristone Exelgyn Brand
Mifepristonum
Mifepristonum [Latin]
MLS000069785
MLS001074115
MolPort-003-849-222
NCGC00025179-05
NCGC00025179-08
NCGC00179632-01
nchembio.313-comp12
NVP-LAQ 824
NVP-LAQ824
NVP-LAQ824, Dacinostat, LAQ824
Pictovir
Pictovir (TM)
Prestwick_570
Prestwick0_000299
Prestwick1_000299
Prestwick2_000299
Prestwick3_000299
R 38486
R38486
R-38486
RU 38486
RU 486
RU 486-6
RU38486
RU-38486
RU486
RU-486
RU-486, MIFEPRISTONE
RU-486, RU-38486, Mifegyne, Mifeprex, Mifepristone
S1095_Selleck
S1611_Selleck
SAM001246881
SMR000058481
SPBio_002457
Spectrum5_002045
TL8005515
UNII-320T6RNW1F
UNII-V10P524501
VGX-410
VGX-410C
VX-410
ZINC03831128
ZK 98296
ZK98296
ZK-98296
|
|
16 |
|
Dopamine |
Approved |
Phase 4 |
|
51-61-6, 62-31-7 |
681 |
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
|
Hydroxytyramin
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
17 |
|
Methylphenidate |
Approved, Investigational |
Phase 4 |
|
113-45-1 |
4158 |
Synonyms:
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
298-59-9 (hydrochloride)
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
4311/B Ciba
AC1L1HJM
alpha-Phenyl-2-piperidineacetate methyl ester
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
a-Phenyl-2-piperidineacetate methyl ester
a-Phenyl-2-piperidineacetic acid methyl ester
C 4311
C07196
Calocain
Celltech brand OF methylphenidate hydrochloride
Centedein
Centedrin
Centedrine
Centredin
Cephalon brand OF methylphenidate hydrochloride
CHEBI:6887
CHEMBL796
CID4158
Concerta
D04999
Daytrana
Daytrana (TN)
DB00422
DB06701
DEA No. 1724
d-methylphenidate HCl
D-Methylphenidate HCL
EINECS 204-028-6
Equasym
Focalin
Focalin XR
HSDB 3126
Hydrochloride, methylphenidate
L001307
LS-565
Mallinckrodt brand OF methylphenidate hydrochloride
Meridil
Metadate
Metadate CD
Metadate ER
Methyl (2-phenyl-2-(2-piperidyl)acetate)
methyl 2-phenyl-2-piperidin-2-ylacetate
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-(2-piperidyl)acetic acid
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl alpha-phenyl-alpha-2-piperidinylacetic acid
Methyl a-phenyl-a-(2-piperidyl)acetate
Methyl a-phenyl-a-(2-piperidyl)acetic acid
Methyl a-phenyl-a-2-piperidinylacetate
Methyl a-phenyl-a-2-piperidinylacetic acid
Methyl phenidate
|
Methyl phenidyl acetate
Methyl phenidylacetate
Methyl phenidylacetic acid
methyl phenyl(piperidin-2-yl)acetate
methyl α-phenyl-α-(2-piperidyl)acetate
Methyl α-phenyl-α-(2-piperidyl)acetate
Methyl α-phenyl-α-(2-piperidyl)acetic acid
methyl α-phenyl-α-2-piperidinylacetate
Methyl α-phenyl-α-2-piperidinylacetate
Methyl α-phenyl-α-2-piperidinylacetic acid
Methylfenidan
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
methylphenidate
Methylphenidate
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
Methylphenidate (USAN/INN)
Methylphenidate [INN:BAN]
Methylphenidate HCl
Methylphenidate HCL
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidic acid
Methylphenidylacetate hydrochloride
Methypatch
MethyPatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MolPort-001-779-620
MPH
nchembio.2007.55-comp28
NCI-C56280
Novartis brand 1 OF methylphenidate hydrochloride
Novartis brand 2 OF methylphenidate hydrochloride
Phenidylate
Plimasine
PMS-Methylphenidate
Riphenidate
Ritalin
Ritalin hydrochloride
Ritalin LA
Ritalin SR
Ritaline
Ritalin-SR
Ritcher works
Ritcher Works
Tsentedrin
UNII-207ZZ9QZ49
α-phenyl-2-piperidineacetate methyl ester
α-phenyl-2-piperidineacetic acid methyl ester
|
|
18 |
|
Eszopiclone |
Approved, Investigational |
Phase 4 |
|
138729-47-2 |
969472 |
Synonyms:
( )-Zopiclone
(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate
(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylic acid
(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate
(+)-Zopiclone
(5S)-6-(5-chloropyridin-2-yl)-7-oxo-5H,6H,7H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate
(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
(plus)-Zopiclone
(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate
(S)-Zopiclone
[(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
138729-47-2
1-Piperazinecarboxylic acid, 4-methyl-, (5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester
1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester
AC1LJ6QN
AC1Q3ZTD
AC-5546
CHEBI:53760
CHEMBL1522
CID969472
CPD000550478
D02624
DB00402
Esopiclone
Estorra
|
Estorra (TN)
Eszopiclone
Eszopiclone (JAN/USAN/INN)
Eszopiclone [USAN:INN]
HSDB 7472
KS-1055
LS-186538
LS-187032
LS-187790
Lunesta
Lunesta (TN)
Lunivia
MLS001165744
MolPort-002-885-823
MolPort-003-666-599
NCGC00159515-02
SAM002548982
SEP-0227018
SEP-0227108
SEP-190
SEP-225441
SMR000550478
SPECTRUM1505188
UNII-UZX80K71OE
ZINC19632834
|
|
19 |
|
Promethazine |
Approved, Investigational |
Phase 4 |
|
60-87-7 |
4927 |
Synonyms:
(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(2-dimethylamino-2-Methyl)ethyl-N-dibenzoparathiazine
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(Dimethylamino-2-propyl-10-phenothiazine hydrochloride
10-(2-(Dimethylamino)-2-methylethyl)phenothiazine
10-(2-(Dimethylamino)propyl)phenothiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(dimethylamino)propyl]phenothiazine
10-[2-(dimethylamino)Propyl]phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl- (9CI)
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, radical ion(1+)
3277 RP
3389 R.p.
38878-40-9
4182 R.p.
4-27-00-01253 (Beilstein Handbook Reference)
60-87-7
73745-50-3
A-91033
AB00053535
AC-15939
AC1L1J92
Antiallersin
Aprobit
Atosil
Avomine
BPBio1_000744
BRN 0088554
BSPBio_000676
BSPBio_002777
C07404
Camergan
CCRIS 7056
CHEBI:8461
CHEMBL643
CID4927
D00494
DB01069
Dimapp
Dimethylamino-isopropyl-phenthiazin
Dimethylamino-isopropyl-phenthiazin [German]
Diphergan
Diprazin
Diprazine
Diprozin
DivK1c_000005
EINECS 200-489-2
Fargan
Fenazil
Fenetazina
Fenetazine
Genphen
Hiberna
Histargan
HMS2089E08
HSDB 3173
Hydrochloride, promethazine
IDI1_000005
Iergigan
InChI=1/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3
Isophenergan
Isopromethazine
KBio1_000005
KBio2_001348
KBio2_003916
KBio2_006484
KBio3_001997
KBioGR_001697
KBioSS_001348
L000495
Lercigan
Lergigan
Lilly 01516
Lilly 1516
Lopac0_000899
LS-264
Metaryl
MolPort-001-783-684
N-(2'-dimethylamino-2'-methyl)ethylphenothiazine
N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,α-trimethyl-10H-phenothiazine-10-ethanamine
|
N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine hydrochloride
NCGC00015817-10
NCGC00089735-02
NCGC00089735-03
NCI60_001878
NCI-C60673
N-Dimethylamino-2-methylethyl thiodiphenylamine
NINDS_000005
NSC 30321
NSC30321
Oprea1_758749
Pelpica
Phargan
Phenargan
Phenergan
Phenerzine
Phenoject-50
Phensedyl
Pilothia
Pilpophen
Pipolfen
Pipolphen
Pipolphene
Prestwick0_000888
Prestwick1_000888
Prestwick2_000888
Prestwick3_000888
Pro-50
Proazaimine
Proazamine
Procit
Promacot
Promazinamide
Promergan
Promesan
Promet
Prometasin
Prometazin
Prometazina
Prometazina [INN-Spanish]
Prometazine
Prometh
Promethacon
Promethaine
Promethazin
promethazine
Promethazine
Promethazine (JAN/INN)
PROMETHAZINE (SEE ALSO PROMETHAZINE HYDROCHLORIDE 58-33-3)
Promethazine [INN:BAN]
Promethazine hydrochloride
PromethazineHcl
Promethazinum
Promethazinum [INN-Latin]
Promethegan
Promethiazine
Promezathine
Prorex
Protazine
Prothazin
Prothazine
Provigan
Pyrethia
Pyrethiazine
Remsed
Romergan
RP 3277
Rumergan
SKF 1498
SPBio_000799
SPBio_002895
Spectrum_000868
Spectrum2_000840
Spectrum3_001019
Spectrum4_001149
Spectrum5_000977
Tanidil
Thiergan
UNII-FF28EJQ494
Valergine
Vallergine
WLN: T C666 BN ISJ B1Y1&N1&1
WY 509
Zipan-25
|
|
20 |
|
Suvorexant |
Approved, Investigational |
Phase 4 |
|
1030377-33-3 |
|
Synonyms:
|
21 |
|
Diphenhydramine |
Approved, Investigational |
Phase 4 |
|
58-73-1, 147-24-0 |
3100 |
Synonyms:
147-24-0
147-24-0 (HYDROCHLORIDE)
2-(benzhydryloxy)-N,N-dimethylethylamine
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-(Benzhydryloxy)-N,N-dimethylethylamine, hydrochloride
2-(diphenylmethoxy)-N,N-dimethylethanamine
2-(Diphenylmethoxy)-N,N-dimethylethylamine
2-[(diphenylmethyl)oxy]-N,N-dimethylethanamine
2-benzhydryloxyethyl-N,N-dimethylammonium
2-benzhydryloxy-N,N-dimethylethanamine
2-diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
2PM
58-73-1
88637-37-0 (citrate (1:1))
a-(2-Dimethylaminoethoxy)diphenylmethane
AB00053460
AC-13704
AC1L1F65
AKOS003658554
Aleryl
Alledryl
Allerdryl
Allergan
Allergan B
Allergeval
Allergical
Allergina
Allergival
Allermax Caplets
Aller-Med
alpha-(2-Dimethylaminoethoxy)diphenylmethane
Amidryl
Antistominum
Antitussive
Antomin
Automin
Bagodryl
Banophen
Banophen Caplets
Baramine
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
Beldin
Belix
Bena
Benachlor
Benadrin
Benadryl
Benadryl (hydrochloride)
Benadryl Allergy
BENADRYL HCl
Ben-allergin
Benapon
Bendylate
Benhydramin
Benodin
Benodine
Benylan
Benylin
Benzantin
Benzantine
Benzhydramine
Benzhydraminum
Benzhydril
Benzhydroamina
Benzhydryl
beta-Dimethylamino-aethyl-benzhydryl-aether
beta-Dimethylamino-aethyl-benzhydryl-aether [German]
beta-Dimethylaminoethanol diphenylmethyl ether
beta-dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethylbenzhydrylether
Betramin
BIDD:GT0152
BPBio1_000275
BRD-K47278471-003-05-7
BRN 1914136
BSPBio_000249
BSPBio_002219
CAS-147-24-0
CCRIS 1959
CHEBI:127629
CHEBI:4636
CHEMBL657
CID3100
Citrate, diphenhydramine
Compoz
CPD-10890
D00300
Dabylen
DB01075
DB06975
Debendrin
Dermistina
Dermodrin
Desentol
Diabenyl
Diabylen
Dibendrin
Dibenil
Dibondrin
Difedryl
Difenhidramina
Difenhidramina [INN-Spanish]
Difenhydramin
Difenhydramine
Difenidramina
Difenidramina [Italian]
Dihidral
Dimedrol
Dimedrol base
Dimedrolum
Dimedryl
Dimehydrinate
|
Dimethylamine benzhydryl ester
Diphamine
Diphantine
Diphen
Diphen Cough
Diphenhist
Diphenhist Captabs
diphenhydramine
Diphenhydramine
Diphenhydramine (JP15/INN)
Diphenhydramine [INN:BAN:JAN]
Diphenhydramine Base
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
Diphenhydramine HCl
Diphenhydramine hydrochloride
DIPHENHYDRAMINE, ANTISTOMINUM, BENZHYDRAMINE
Diphenhydraminum
Diphenhydraminum [INN-Latin]
Diphenylhydramin
Diphenylhydramine
DivK1c_000368
Dobacen
Dormarex 2
Dormin
Dryistan
Drylistan
Dylamon
EINECS 200-396-7
Etanautine
FAR 90X2
Genahist
Histaxin
HMS2089E06
HSDB 3066
Hyadrine
Hydramine
Hydrochloride, diphenhydramine
Hyrexin
I14-6749
Ibiodral
IDI1_000368
KBio1_000368
KBio2_001460
KBio2_004028
KBio2_006596
KBio3_001439
KBioGR_001099
KBioSS_001460
L000227
Lopac0_000377
Lopac-D-3630
LS-68208
Medidryl
Mephadryl
MLS002222276
MolPort-001-783-508
N-(2-(diphenylmethoxy)ethyl)-N,N-dimethylamine
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
N-(Benzhydryloksy-etylo)dwumetyloamina
N-(Benzhydryloksy-etylo)dwumetyloamina [Polish]
N,N-Dimethyl-2-(diphenylmethoxy)-ethylamine hydrochloride
N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE
Nausen
NCGC00015335-01
NCGC00015335-02
NCGC00015335-03
NCGC00015335-10
NCGC00024414-03
NCGC00024414-04
nchembio747-comp18
NCI60_002916
NCI60_022782
Nervine Nighttime Sleep-Aid
NINDS_000368
Novamina
NSC665800
Nytol Quickcaps
Nytol Quickgels
O-benzhydryldimethylaminoethanol
O-Benzhydryldimethylaminoethanol
Oprea1_254625
PM 255
Prestwick0_000065
Prestwick1_000065
Prestwick2_000065
Prestwick3_000065
Probedryl
Restamin
Restamin (TN)
Rigidil
S51
Siladryl
Silphen
Sleep-Eze D
Sleep-Eze D Extra Strength
SMR001307259
SPBio_000961
SPBio_002170
Spectrum_000980
Spectrum2_000961
Spectrum3_000400
Spectrum4_000520
Spectrum5_000915
STK103720
STOCK2S-94461
Syntedril
Syntodril
TL8003758
Twilite Caplets
UNII-8GTS82S83M
Unisom Sleepgels Maximum Strength
α-(2-dimethylaminoethoxy)diphenylmethane
β-dimethylaminoethanol diphenylmethyl ether
β-dimethylaminoethyl benzhydryl ether
|
|
22 |
|
Sertraline |
Approved |
Phase 4 |
|
79617-96-2 |
68617 |
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-sertraline
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-Dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Altruline
apo Sertraline
apo-Sertraline
Apo-Sertraline
Apotex brand OF sertraline hydrochloride
Aremis
Besitran
BIDD:GT0768
BIDD:PXR0193
Boehringer ingelheim brand OF sertraline hydrochloride
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
cis-(+)-sertraline
cis-(+)-Sertraline
Cp 51974
CP 51974
D02360
DB01104
DB08567
Esteve brand OF sertraline hydrochloride
FT-0081122
Gen sertraline
Genpharm brand OF sertraline hydrochloride
Gen-sertraline
Gladem
HSDB 7037
Hydrochloride, sertraline
|
KBio3_001918
KBioGR_001724
Lacer brand OF sertraline hydrochloride
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
novo Sertraline
Novopharm brand OF sertraline hydrochloride
novo-Sertraline
Parke davis brand OF sertraline hydrochloride
Pfizer brand OF sertraline hydrochloride
Prestwick3_001014
ratio Sertraline
Ratiopharm brand OF sertraline hydrochloride
ratio-Sertraline
Rhoxal sertraline
Rhoxalpharma brand OF sertraline hydrochloride
Rhoxal-sertraline
Roerig brand OF sertraline hydrochloride
Sealdin
Sertralina
Sertralina [Spanish]
sertraline
Sertraline
Sertraline (INN)
sertraline (Zoloft)
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertraline Hydrochloride
Sertraline hydrochloride (1S-cis)-isomer
Sertralinum
Sertralinum [Latin]
SMR000596516
SPBio_000385
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
SRE
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
|
|
23 |
|
Alprazolam |
Approved, Illicit, Investigational |
Phase 4 |
|
28981-97-7 |
2118 |
Synonyms:
28981-97-7
611026_ALDRICH
611026_FLUKA
8-Chloro-1-methyl-6-(phenyl-d5)-4H-(1,2,4)triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
8-chloro-1-Methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-alpha)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine
A6551_FLUKA
A6551_SIGMA
A8800_SIGMA
AC-18721
AC1L1CYL
AKOS005066050
Alcelam
Algad
Alpaz
Alphapharm brand OF alprazolam
Alphapharm Brand of Alprazolam
Alplax
Alpram
Alprax
alprazolam
Alprazolam
Alprazolam (JP15/USP/INN)
Alprazolam [USAN:INN:BAN:JAN]
Alprazolam alphapharm brand
Alprazolam Alphapharm Brand
Alprazolam apotex brand
Alprazolam Apotex Brand
Alprazolam extended release tablets
Alprazolam intensol
Alprazolam kenral brand
Alprazolam Kenral Brand
Alprazolam novopharm brand
Alprazolam Novopharm Brand
Alprazolam nu-pharm brand
Alprazolam Nu-Pharm Brand
Alprazolam orion brand
Alprazolam Orion Brand
Alprazolam pfizer brand
Alprazolam Pfizer Brand
Alprazolam solution
Alprazolam temmler brand
Alprazolam Temmler Brand
Alprazolam-d5
Alprazolamum
Alprazolamum [INN-Latin]
Alprazolan
Alpronax
Alprox
Alviz
Alzam
Alzolam
Alzon
Anpress
AP-1002
apo Alpraz
Apo Alpraz
apo-Alpraz
ApoAlpraz
Apo-Alpraz
Apotex brand OF alprazolam
Apotex Brand of Alprazolam
Arzneimittelwerk dresden brand OF alprazolam
Arzneimittelwerk Dresden Brand of Alprazolam
AZ-002
Azor
Bestrol
BIDD:GT0475
BIDD:PXR0150
Bio-0790
BRN 1223125
C06817
Cassadan
CHEBI:2611
CHEMBL661
CID2118
Constan
CPD000149316
D 65MT
D000525
D00225
D65MT
D-65MT
DB00404
DEA No. 2882
EINECS 249-349-2
Esparon
Frontal
Gen-Alprazolan
|
Helex
HMS2051A10
HSDB 7207
I14-7472
Intensol
Kalma
Kenral brand OF alprazolam
Kenral Brand of Alprazolam
Ksalol
LS-156344
Mialin
MLS000559000
MLS000759485
MolPort-002-507-836
NCGC00159466-02
NCGC00159466-03
nchembio747-comp35
Neurol
Niravam
novo Alprazol
Novo Alprazol
novo-Alprazol
NovoAlprazol
Novo-Alprazol
Novopharm brand OF alprazolam
Novopharm Brand of Alprazolam
Nu alpraz
Nu Alpraz
Nu pharm brand OF alprazolam
Nu Pharm Brand of Alprazolam
Nu-alpraz
NuAlpraz
Nu-Alpraz
Nu-pharm brand OF alprazolam
Nu-Pharm Brand of Alprazolam
Orion brand OF alprazolam
Orion Brand of Alprazolam
Panistat
Panix
Pfizer brand OF alprazolam
Pfizer Brand of Alprazolam
Pharnax
Prazam
Prazolan
Prinox
Ralozam
Relaxol
Restyl
SAM001246696
SMR000149316
Solanax
Staccato-alprazolam
STK590494
Tafil
Tafil D
Temmler brand OF alprazolam
Temmler Brand of Alprazolam
Tensivan
TGAR01P
Tranax
Trankimazin
Tranquinal
Tricalma
Tus 1
TUS-1
U 31889
U31,889
U-31,889
U-31889
UNII-YU55MQ3IZY
Unilan
Valeans
Xanagis
Xanax
Xanax (TN)
Xanax TS
Xanax XR
Xanolam
Xanor
Zacetin
Zanapam
Zaxan
Zenax
ZINC00000903
Zolam
Zolan
Zolarem
Zoldac
Zoldax
Zopax
Zopic
Zotran
|
|
24 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
25 |
|
Cyclooxygenase 2 Inhibitors |
|
Phase 4 |
|
|
|
26 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
27 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
28 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 4 |
|
|
|
29 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
30 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
31 |
|
Anesthetics |
|
Phase 4 |
|
|
|
32 |
|
Anesthetics, General |
|
Phase 4 |
|
|
|
33 |
|
Serotonin and Noradrenaline Reuptake Inhibitors |
|
Phase 4 |
|
|
|
34 |
|
Duloxetine Hydrochloride |
|
Phase 4 |
|
|
|
35 |
|
Analgesics |
|
Phase 4 |
|
|
|
36 |
|
Adrenergic beta-Antagonists |
|
Phase 4 |
|
|
|
37 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
38 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
39 |
|
Adrenergic Antagonists |
|
Phase 4 |
|
|
|
40 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
41 |
|
Quetiapine Fumarate |
|
Phase 4 |
|
111974-72-2 |
|
42 |
|
Antipsychotic Agents |
|
Phase 4 |
|
|
|
43 |
|
Serotonin 5-HT1 Receptor Agonists |
|
Phase 4 |
|
|
|
44 |
|
Serotonin 5-HT3 Receptor Antagonists |
|
Phase 4 |
|
|
|
45 |
|
Dopamine Antagonists |
|
Phase 4 |
|
|
|
46 |
|
Dopamine agonists |
|
Phase 4 |
|
|
|
47 |
|
Contraceptive Agents |
|
Phase 4 |
|
|
|
48 |
|
Contraceptives, Oral |
|
Phase 4 |
|
|
|
49 |
|
Excitatory Amino Acid Antagonists |
|
Phase 4 |
|
|
|
50 |
|
Anesthetics, Dissociative |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 378)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release |
Unknown status |
NCT00492414 |
Phase 4 |
Paroxetine CR |
2 |
Study Proposal - A Randomized Double-blinded Study Comparing Adding Etoricoxib Versus Placebo to Female Patients With Fibromyalgia-analysis of Organic and Psychiatric Measures |
Unknown status |
NCT00755521 |
Phase 4 |
etoricoxib |
3 |
A Randomized, Double-Blind, Multicenter Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder |
Completed |
NCT00677352 |
Phase 4 |
sertraline;Paroxetine |
4 |
Phase 4 Study of Panic Disorder That Expresses to Change of Cerebral Glucose Metabolism After 12 Week of Paroxetine Treatment |
Completed |
NCT00767754 |
Phase 4 |
Paxil CR |
5 |
The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder |
Completed |
NCT00438971 |
Phase 4 |
Duloxetine |
6 |
Changes of Cerebral Glucose Metabolism Associated With the Fear Network Activity Before and After 12 Weeks of Escitalpram Treatment in Panic Disorder |
Completed |
NCT00767871 |
Phase 4 |
Lexapro |
7 |
Randomized Controlled Trial of Escitalopram Versus Placebo for Patients With Irritable Bowel Syndrome and Panic Disorder |
Completed |
NCT01551225 |
Phase 4 |
Escitalopram |
8 |
A Randomized, Controlled Trial on the Effects of Paroxetine Versus Placebo in Combination With Aerobic Exercise or Relaxation Training in the Treatment of Panic Disorder |
Completed |
NCT00540098 |
Phase 4 |
paroxetine + aerobic exercise;Paroxetine + relaxation;Placebo + aerobic exercise;Placebo + relaxation |
9 |
The Effects of Treatment With Sertraline for Panic Disorder and/or Depression Driven Chest Pain and/or Palpitations in a Double Blind, Care as Usual and Placebo Controlled Study |
Completed |
NCT01114100 |
Phase 4 |
sertraline;placebo |
10 |
An 8-week, Randomized, Double-Blind, Placebo-Controlled Trial of Seroquel SR Co-administration for SSRI-Resistant, Comorbid Panic Disorder |
Completed |
NCT00619892 |
Phase 4 |
quetiapine XR;placebo |
11 |
A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder |
Completed |
NCT02395510 |
Phase 4 |
Vortioxetine |
12 |
A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Current at Least Moderately Severe Anxiety and Lifetime Panic Disorder or Generalized Anxiety Disorder |
Completed |
NCT00167479 |
Phase 4 |
risperidone (Risperdal) |
13 |
Aripiprazole for the Treatment of Refractory Anxiety: Impact on Clinical Outcomes, Resilience and Neuroendocrinologic Parameters |
Completed |
NCT00438386 |
Phase 4 |
Aripiprazole |
14 |
Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment: a Clinical Randomized Trial |
Completed |
NCT00803400 |
Phase 4 |
Alprazolam;Alprazolam + Aerobic exercise |
15 |
Combined Treatment With A Benzodiazepine (Clonazepam) And A Selective Serotonin Reuptake Inhibitor (Paroxetine) For Rapid Treatment Of Panic Disorder With Depression |
Completed |
NCT00031317 |
Phase 4 |
Paroxetine;Clozapine |
16 |
A Randomized Double-Blind Comparison of Sertraline With Early Alprazolam XR Co-Administration vs Sertraline/Placebo for Primary Care Panic Disorder Patients |
Completed |
NCT00198094 |
Phase 4 |
Sertraline and Alprazolam XR |
17 |
A Multicenter, Randomized, Open-label, Parallel Design Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravamâ„¢ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder |
Completed |
NCT00266409 |
Phase 4 |
Niravam;SSRI/SNRI |
18 |
Long-term, Open, Naturalistic, Randomized Clinical Trial With Clonazepam and Paroxetine in Panic Disorder With or Without Agoraphobia |
Completed |
NCT02852577 |
Phase 4 |
Clonazepam;Paroxetine |
19 |
A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder |
Completed |
NCT01172652 |
Phase 4 |
Ziprasidone;Placebo |
20 |
Coordinated Anxiety Learning and Management (CALM): Improving Primary Care Anxiety Outcomes |
Completed |
NCT00347269 |
Phase 4 |
Psychotropic medication optimization |
21 |
A Randomized, Double-blind, Placebo-controlled Study of Quetiapine SR and Divalproex Sodium ER on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder. |
Completed |
NCT00579280 |
Phase 4 |
quetiapine SR;divalproex sodium ER;placebo |
22 |
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients (MOSAIC) |
Completed |
NCT01201967 |
Phase 4 |
|
23 |
A Randomized Controlled Trial of Cognitive Behavioural Therapy for Non-cardiac Chest Pain and Palpitations. |
Completed |
NCT00623454 |
Phase 4 |
|
24 |
12 Week Prospective Double Blind Placebo Controlled Randomized Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety |
Completed |
NCT00352469 |
Phase 4 |
Seroquel XR |
25 |
Investigation of Genetic Predictors of the Response to SSRI Treatment |
Completed |
NCT03927950 |
Phase 4 |
escitalopram;bupropion |
26 |
Efficacy of Rapid-Acting NMDA Antagonist for Treatment of Adolescent Depression and Anxiety Disorders |
Completed |
NCT02579928 |
Phase 4 |
Ketamine;Midazolam |
27 |
Aripiprazole (Abilify) Therapy for Reducing Comorbid Substance Abuse |
Completed |
NCT00208169 |
Phase 4 |
Aripiprazole |
28 |
A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and Tolerability of Immediate-Release Formulation of Quetiapine Fumarate as Potentiation of Selective Serotonin Reuptake Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors Treatment in Major Depression With Comorbid Anxiety Symptoms |
Completed |
NCT00229645 |
Phase 4 |
Quetiapine Fumarate (Seroquel®) |
29 |
A Pilot Study to Treat Emotional Disorders in Primary Care With Evidence-based Psychological Techniques: A Randomized Controlled Trial |
Completed |
NCT01903096 |
Phase 4 |
Primary Care Treatment As Usual |
30 |
Single-Site, Double-Blind, Flexible-Dose, Placebo-Controlled Study of the Efficacy, Tolerability, & Safety of Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS) |
Completed |
NCT00610909 |
Phase 4 |
Paroxetine CR;Placebo |
31 |
Pharmacotherapy in Depression With Panic Spectrum |
Completed |
NCT00177996 |
Phase 4 |
sertraline hydrochloride |
32 |
Cannabinoid Control of Fear Extinction Neural Circuits in Humans |
Completed |
NCT02472847 |
Phase 4 |
Dronabinol;Placebo |
33 |
Psychophysiology of Delayed Extinction and Reconsolidation in Humans |
Completed |
NCT01631682 |
Phase 4 |
Propranolol;Mifepristone;Intranasal oxytocin |
34 |
Comparative Effectiveness of Mindfulness-Based Stress Reduction and Pharmacotherapy for Anxiety |
Recruiting |
NCT03522844 |
Phase 4 |
Escitalopram |
35 |
A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity |
Recruiting |
NCT03785223 |
Phase 4 |
Methylphenidate Hydrochloride Controlled-Release Capsules;Placebo Capsule |
36 |
A Pragmatic Randomized Comparator Trial of Eszopiclone and Brief Behavioral Therapy for Insomnia in CPAP Non Adherent Veterans With PTSD and Complex Insomnia |
Recruiting |
NCT03937713 |
Phase 4 |
eszopiclone |
37 |
The Role of Orexin in Human Panic Disorder |
Active, not recruiting |
NCT02593682 |
Phase 4 |
suvorexant;placebo |
38 |
Effects of Perampanel on Neurophysiology Test Perimeters |
Suspended |
NCT03653741 |
Phase 4 |
Perampanel 6 MG |
39 |
An Open-Label Study to Assess the Safety and Tolerability of Xanax XR in the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks |
Terminated |
NCT00634790 |
Phase 4 |
alprazolam XR |
40 |
A Randomized, Double-Blind, Placebo-Controlled Study of Xanax XR in the Treatment of Adolescents With a Primary Diagnosis of Panic Disorder |
Terminated |
NCT00635531 |
Phase 4 |
alprazolam XR |
41 |
A Randomized, Double-Blind, Placebo-Controlled Study of Continuation Treatment With Xanax XR in the Treatment of Adolescents With a Primary Diagnosis of Panic Disorder |
Terminated |
NCT00635076 |
Phase 4 |
alprazolam XR |
42 |
Sertraline in the Treatment of Generalized Social Phobia With Comorbidity |
Terminated |
NCT00182533 |
Phase 4 |
Sertraline;Placebo |
43 |
Mechanisms of CBT-Treatment Effects in Patients With Panic Disorder and Panic Disorder With Agoraphobia: The Role of Interoceptive Exposure |
Unknown status |
NCT01323556 |
Phase 2, Phase 3 |
|
44 |
A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder |
Completed |
NCT00038896 |
Phase 3 |
Venlafaxine ER |
45 |
A Double-blind, Placebo-controlled, Parallel-group Comparison of Venlafaxine Extended-release Capsules and Paroxetine in Outpatients With Panic Disorder |
Completed |
NCT00044772 |
Phase 3 |
Venlafaxine ER |
46 |
Pilot Study of Venlafaxine Extended Release (XR) in the Treatment of Panic Disorder (PD) in Comparison to Paroxetine. |
Completed |
NCT00195598 |
Phase 3 |
VENLAFAXINE;Paroxetine |
47 |
Randomized Controlled Trial of Psychodynamic Psychotherapy vs. Applied Relaxation for Panic Disorder |
Completed |
NCT00128388 |
Phase 2, Phase 3 |
|
48 |
Treatment Refractory Panic Disorder |
Completed |
NCT00118417 |
Phase 2, Phase 3 |
Clonazepam;Sertraline |
49 |
Internet- Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder in a Psychiatric Setting: A Randomized Equivalence Trial |
Completed |
NCT00845260 |
Phase 3 |
|
50 |
A Randomized, Controlled Study of a Stepped-care Model for the Treatment of Social Phobia and Panic Disorder in Adults |
Completed |
NCT00619138 |
Phase 3 |
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Alprazolam
Clomipramine
Clomipramine Hydrochloride
Clonazepam
Diazepam
Fluoxetine
Fluoxetine Hydrochloride
Fluvoxamine
Fluvoxamine Maleate
Imipramine
Imipramine Hydrochloride
|
Imipramine pamoate
Maprotiline
Maprotiline Hydrochloride
Paroxetine
Paroxetine Hydrochloride
Propranolol
Propranolol Hydrochloride
Sertraline
Sertraline Hydrochloride
Temazepam
|
Cochrane evidence based reviews: panic disorder
|